The active ingredient tirzepatide has FDA approval in branded forms (Zepbound and Mounjaro), but the specific compounded formulation with B12 that Trava provides has not gone through the FDA approval process
Mass spectrometry only measures for what we are looking for, whereas ELISA can also cover metabolites of the toxins we are looking for
Ubiquitination assays comparing *NSD2 PWWP1 mutants were performed similarly, except that SKP1-FBXO22, *NSD2 PWWP1 mutants, and compounds were not incubated separately prior to the start of the reaction
High-dose oral glutathione or liposomal glutathione (a formulation designed for better absorption) might be next in line to try
Stacking these two could potentially amplify tissue repair mechanisms, creating a more robust healing environment in research models
Biotechnol Bioeng 117(5):14261435